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Collapse of Immune Privilege  
in Alopecia Areata:  
Coincidental or Substantial?
Amos Gilhar1,2
Only indirect evidence supports the concept that a collapse of immune privilege 
(IP) in hair follicles leads to the development of alopecia areata (AA). In this 
issue, Kang et al. provide further evidence to support this theory, demonstrating 
downregulation of the expression of several genes important for the immuno-
suppressive environment in lesional and perilesional areas of AA.
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the immune privilege of critical organs
Investigators have long been curious 
about the ability of critical organs to 
survive for long periods of time, pro-
tected from inflammatory reactions and 
foreign invasion. Even in an immune-
compromised environment, various 
critical organs and tissues are protected 
from immune-mediated inflammation 
that might otherwise affect the function 
of vital tissues and threaten organ sur-
vival. The Dutch ophthalmologist van 
Dooremaal (1873) described the phe-
nomenon of immune privilege (IP) by 
demonstrating the prolonged survival of 
mouse skin grafts placed in the anterior 
chamber of a dog’s eye. Later, Medawar 
(1948) studied the fate of allogenic 
skin grafts transplanted into the ante-
rior chamber of the eye and brains of 
rabbits, discovering that, in contrast 
to allografts inserted into other body 
sites (including the skin itself), those 
transplanted into the eye and brain sur-
vived much longer. Thus, historically, 
IP sites are defined as areas in the body 
where foreign tissue grafts can survive 
for extended or indefinite periods of 
time, whereas similar grafts placed in 
conventional body sites are acutely 
rejected. IP is most probably crucial for 
the survival of three organs: the brain, 
the eye, and the pregnant uterus. In an 
evolutionary sense, these organs are 
vital for survival, and immune-mediat-
ed inflammation in any of these organs 
could have devastating consequences.
Immune privilege of hair follicles
Over the past two decades, it has been 
suggested that normal hair follicles rep-
resent an IP site, indicating a possible 
evolutionary change in the role of hair 
over the ages. The Billingham mouse 
experiment (Billingham and Silvers, 
1971) provided the first clue regarding 
the immune protection of hair folli-
cles—in a model of skin grafts of black 
guinea pigs transplanted to the white 
skin of an incompatible recipient strain, 
the donor’s melanocytes immigrated 
and survived for a long time within host 
hair follicles, in sharp contrast to their 
fate among epidermal melanocytes.
The characteristic features of the eye’s 
IP might serve as an example of pure 
IP: lack of lymphatic drainage, immu-
nosuppressive effects of the aqueous 
humor itself, low major histocompat-
ibility complex (MHC) expression, low 
numbers of Langerhans cells or other 
antigen-presenting cells, and inhibition 
of natural killer cells. Similarly, normal 
hair follicles do not express MHC class 
I and class II molecules; there are only a 
few Langerhans cells around and within 
hair follicles, and they have function-
al impairment because they do not 
express MHC class II molecules, which 
normally play roles in antigen presenta-
tion. Furthermore, immunosuppressive 
cytokines are expressed prominently 
by the follicular epithelium. These cyto-
kines are believed to maintain the IP of 
the hair follicles and to induce periph-
eral tolerance (Gilhar et al., 2007). Ito 
et al. (2008) demonstrated the strong 
expression of the potent NK-cell inhibi-
tor MIF, which prevents the accumu-
lation of NK cells around and within 
hair follicles. Recently, Petukhova et 
al. (2010) described a genome-wide 
association study in which they iden-
tified several genetic susceptibility 
loci for alopecia areata (AA), most of 
which were clustered in eight genomic 
regions. The spectrum of affected gene 
activities implies the involvement of 
both acquired and innate immunity in 
the disease. Significant associations 
include the ULBP genes, which encode 
activating ligands for the NK cell recep-
tor, NKG2D. NKG2D/ULBP3 engage-
ment might be responsible for the 
destructive effect observed in affected 
tissues. Normally, ULBP3 is not present 
in hair follicles, but in Petukhova and 
colleagues’ study ULBP3 proteins were 
abundant in the hair follicles affected by 
alopecia areata. Collectively, these find-
ings support a role for IP in hair growth.
collapse of IP in aa: true or false?
AA is a noncontagious, incurable skin 
disease that appears mostly as bald 
patches of the scalp. The disease is char-
acterized by a complexity of events, 
and multiple genes, hormones, growth 
factors, and inflammatory molecules 
have been found to play roles in its 
pathogenesis. Previously, we showed 
that it is possible to transfer AA to scalp 
explants on severe combined immuno-
deficiency mice by injecting autologous 
scalp-derived T cells from patients with 
AA (Gilhar et al., 1998). The scalp T cells 
were cultured with a follicular homoge-
nate prior to injection into the explants. 
The histological and immunohistologi-
cal profile of the explants demonstrated 
characteristic features of AA, including 
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increased expression of MHC class I 
and II molecules by the follicular epi-
thelium. Paus et al. (1994) hypothesized 
that the induction of MHC class I mol-
ecules on hair follicle epithelium leads 
to the collapse of IP because ectopic 
MHC class I molecule expression is the 
logical key prerequisite for autoantigens 
being exposed at all. These investigators 
speculated that the collapse of IP is the 
key to the induction of AA. Hair follicle 
IP is considered to have involvement at 
multiple levels in AA, including roles 
for cell receptors, cytokines, chemo-
kines, and physical barriers. Thus, IP col-
lapse would presumably require several 
steps rather than simply the induction 
of MHC class I and II molecule expres-
sion. Direct functional evidence for IP 
collapse could be provided by showing 
that “IP-intact” mouse hair follicles can 
harbor and immune-protect an alloanti-
gen, whereas “IP-defective” hair follicles 
would reject such an antigen. However, 
to date, only indirect evidence supports 
the concept of IP collapse in the patho-
genesis of AA. Therefore, the study by 
Kang et al. (2010, this issue) is of particu-
lar importance because the investigators 
therein report solid data demonstrating 
the downregulation of IP genes in unin-
volved scalp areas of patients with AA.
Lesional versus perilesional areas in aa
A crucial question is whether the col-
lapse of hair follicle IP in AA is a sec-
ondary event of the “storm”-like events 
that precipitate in AA. Kang et al. (2010) 
provide data regarding IP gene expres-
sion in both lesional and unaffected 
perilesional areas. Comparing gene 
and protein expression in involved 
and uninvolved areas might indicate 
patients’ susceptibility to hair loss. 
Indeed, several genes were upregu-
lated in both areas, including IL-1Ra 
and CD80. Previously, it was suggested 
that IL-1Ra is associated with AA and 
involved in its pathogenesis. CD80 
molecules are expressed by dendritic 
cells and are needed to activate T cells. 
The current study showed that FasL, a 
molecule known to induce apoptosis of 
activated T cells and neutrophils, was 
decreased significantly in lesional but 
not in unaffected perilesional areas. It 
is well recognized that FasL is crucial in 
promoting eye, brain, and fetal IP. The 
potent immunosuppressive cytokines, 
α-melanocyte-stimulating hormone 
(α-MSH) and transforming growth 
factor-β (TGF-β), which are assumed to 
maintain hair follicle IP and are known 
to be decreased in the involved areas 
of AA, were downregulated in both the 
involved and uninvolved areas.
Furthermore, two striking immuno-
suppressive agents that have not been 
detected previously in AA were found 
to be decreased significantly, mostly 
in the perilesional areas: the lympho-
cyte proliferation inhibitor indole-
amine 2,3-dioxygenase (IDO) and 
Red/IK. The role of IDO in the immune 
system remains a subject of active 
investigation, including its role in the 
eye. Recent studies have shown that 
enhanced IDO activity plays an impor-
tant role in inducing immunological 
tolerance in many Th1-mediated auto-
immune diseases, such as experimental 
autoimmune encephalomyelitis (Hou et 
al., 2009). The second immunosuppres-
sive component that was significantly 
downregulated in the lesional and non-
lesional areas of AA is the IK cytokine, 
which has been isolated as a factor 
that inhibits IFN-γ-induced expres-
sion of MHC class II antigens. Aberrant 
expression of MHC class II antigens has 
reportedly been recognized in the tar-
get organs of autoimmune diseases and 
has been associated with disease activ-
ity (Muraoka et al., 2006). Kang et al. 
(2010) provide novel evidence of two 
potent immunosuppressive compo-
nents in normal scalp skin, supporting 
the role of IP in normal hair follicles. 
Even more importantly, the significant 
downregulation of immunosuppressive 
Figure 1. Pathogenic model of alopecia areata. The normal hair follicle represents a site of 
immune privilege (IP). The guardians of IP include immunosuppressive cytokines such as 
α-melanocyte stimulating hormone (α-MSH), transforming growth factor-β (TGF-β), IK, indoleamine 
2,3-dioxygenase (IDO), and IL-10. Patients with a specific genetic background are susceptible to 
developing alopecia areata (AA), most probably by downregulation of this immunosuppressive 
environment. It has been suggested that events such as stress, infection, or microtrauma might lead 
to downregulation of immunosuppressive cytokines. This downregulation enables the accumulation 
of natural killer (NK) cells around hair follicles. Furthermore, stress or other trauma may also 
alter the production of neuropeptides, including substance P (SP) and calcitonin gene–related 
peptide (CGRP). SP may upregulate the production of nerve growth factor, which in turn induces 
accumulation of mast cells around hair follicles. SP causes degranulation of mast cells, leading 
to a release of large amounts of TNF-α, which is known to inhibit hair growth. Furthermore, 
SP induces accumulation of CD8+ cells and induce these cells to produce large amounts of 
IFN-γ. IFN-γ, produced by the activated CD8+ cells and the NK cells, induces expression of major 
histocompatibility complex (MHC) class I molecules in the lower part of the follicular epithelium, 
resulting in presentation of follicular autoantigens to the CD8+ cells and loss of IP. IFN-γ also may 
induce MHC class II molecule expression by the follicular epithelium, leading to a second wave of 
CD4+ cells that may bolster CD8+ activity via released cytokines. Treg, regulatory T cell.
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components such as IK and IDO not 
only in lesional but also in perilesional, 
unaffected areas may indicate a col-
lapse of the immunosuppressive envi-
ronment prior to the massive cellular 
infiltration of perifollicular regions in 
lesional skin. This line of thought may 
support the notion that the collapse of 
IP plays an important role and is proba-
bly not a secondary event in the patho-
genesis of AA.
a scenario of events leading to 
alopecia areata
A crucial and so far unresolved 
question is “What are the initial events 
leading to the development of AA?” 
Several studies have incriminated 
IFN-γ in the pathogenesis of the dis-
ease (Gilhar et al., 2007). However, it is 
unlikely that IFN-γ plays an initial role 
in the pathogenesis of AA because the 
primary source of IFN-γ is activated T 
cells (and it would be difficult to postu-
late activation of T cells prior to the loss 
of IP). It has been proposed that neuro-
peptides, such as the calcitonin gene–
related protein (CGRP) and substance 
P (SP), might have initiating capability 
(Gilhar et al., 2007). CGRP has been 
reported to have an immunosuppres-
sive effect; a lack of CGRP results in 
vasoconstriction and hyperresponsive-
ness (including autoimmunity), both 
of which may play roles in the patho-
genesis of AA. SP-containing nerves 
are present in greater numbers in early 
AA lesions. SP treatment results in a 
moderate accumulation of CD8+ cells 
(Gilhar et al., 2007). Thus, AA is sug-
gested to develop as follows: downreg-
ulation of IK and IDO along with other 
immunosuppressive agents, combined 
with alterations in neuropeptide pro-
duction following infection-associated 
stimuli, stress-associated neurogenic 
inflammation, or other microtrauma, 
facilitates the accumulation of activat-
ed immune cells and the production of 
IFN-γ (Figure 1).
It appears that IFN-γ is unique in 
inducing MHC class I molecules in the 
lower part of the follicular epithelium 
(Gilhar et al., 2007). This induction may 
result in the presentation of follicular 
autoantigens and loss of peripheral toler-
ance. IFN-γ also induces the expression 
of MHC class II molecules by the follic-
ular epithelium. MHC class II molecule 
expression by the affected hair follicles 
may result in a second wave of activated 
CD4 cells. The significant downregula-
tion of IK enables IFN-γ to induce MHC 
class II molecule expression by the fol-
licular epithelium. Thus, the study by 
Kang et al. (2010) may provide addition-
al and important indirect evidence sup-
porting the role of IFN-γ in AA.
How close are we to finding novel 
treatments for aa?
The study by Kang and colleagues 
(2010), among others, could lead to the 
development of specific treatments for 
AA, which to date are unavailable. It 
has been suggested that the pathophys-
iology of AA involves multiple effec-
tors and that interrupting only one 
pathway is insufficient for affecting the 
course of the disease. This is consistent 
with recent studies in which single-
targeted psoriasis treatments did not 
demonstrate efficacy in AA. The results 
of the study by Kang et al. strengthen 
the concept that the reestablishment 
of IP would serve as a therapeutic 
manipulation to reverse the disease 
and prevent its progression. Cytokines 
with the potential to maintain human 
hair follicle IP, such as TGF-β, α-MSH, 
and IL-10, have been proposed for 
use in a novel therapeutic approach. 
A potent IK analog demonstrated its 
ability to ameliorate the progression of 
lupus nephritis (Muraoka et al., 2006), 
whereas further studies into the exact 
nature of IDO in pathogenic mecha-
nisms of AA may lead to the develop-
ment of novel therapies for AA (Hou 
et al., 2009). Our hope is that more 
studies such as those by Kang et al. will 
lead to a better understanding of the 
pathogenesis of AA and to a promise of 
useful therapeutic agents.
CONFLICT OF INTEREST
The author states no conflict of interest.
ReFeReNCeS
Billingham RE, Silvers WK (1971) A biologist’s 
reflections on dermatology. J Invest Dermatol 
57:227–40
Gilhar A, Paus R, Kalish RS (2007) Lymphocytes, 
neuropeptides, and genes involved in alopecia 
areata. J Clin Invest 117:2019–27
Gilhar A, Ullmann Y, Berkutzki T et al. (1998). 
Autoimmune hair loss (alopecia areata) 
transferred by T lymphocytes to human scalp 
explants on SCID mice. J Clin Invest 101:62–7
Hou W, Li S, Wu Y et al. (2009) Inhibition of 
indoleamine 2, 3-dioxygenase-mediated 
tryptophan catabolism accelerates crescentic 
glomerulonephritis. Clin Exp Immunol 
156:363–72
Ito T, Ito N, Saatoff M et al. (2008) Maintenance 
of hair follicle immune privilege is linked to 
prevention of NK cell attack. J Invest Dermatol 
128:1196–206
Kang H, Wu W-Y, Lo BKK et al. (2010) Hair 
follicles from alopecia areata patients exhibit 
alterations in immune privilege–associated 
gene expression in advance of hair loss. 
J Invest Dermatol 130:2677-80
Medawar PB (1948) Immunity to homologous 
grafted skin. III. The fate of skin homografts 
transplanted to the brain, to subcutaneous 
tissue, and to the anterior chamber of the eye. 
Br J Exp Pathol 29:58–69
Muraoka M, Hasegawa H, Kohno M et al. (2006) 
IK cytokine ameliorates the progression of 
lupus nephritis in MRL/lpr mice. Arthritis 
Rheum 54:3591–600
Paus R, Slominski A, Czarnetzki BM (1994) Is 
alopecia areata an autoimmune-response 
against melanogenesis-related proteins, 
exposed by abnormal MHC class I expression 
in the anagen hair bulb? Yale J Biol Med 
66:541–54
Petukhova L, Duvic M, Hordinsky M et al. (2010) 
Genome-wide association study in alopecia 
areata implicates both innate and adaptive 
immunity. Nature 466:113–7
van Dooremaal JC (1873) Die Entwicklung der in 
fremden Grund versetzten lebenden Geweba. 
Albrecht Von Graefes. Arch Ophthalmol 19: 
358–73
Clinical Implications
•  Normal hair follicles are immune-protected sites that lack expression of 
cell surface molecules ordinarily associated with effective immunity.
•  Recent studies indicate that alopecia areata is associated with a loss of 
this immune protection, leading to an effector T-cell response that is 
directed against the hair follicle itself.
•  Current strategies in the development of new therapies include the use 
of immunologically active molecules that return the hair follicle to its 
state of immune protection.
